Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception

β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway

(2011) Allisson Freire Bento et al.   AMERICAN JOURNAL OF PATHOLOGY

The cannabinoid 1 receptor antagonist AM251 produces nocifensive behavior via activation of ERK signaling pathway

(2010) Soh Katsuyama et al.   NEUROPHARMACOLOGY

Cannabinoid Type 2 Receptor as a Target for Chronic - Pain

(2009) Massimiliano Beltramo   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain

(2009) Aldric T. Hama et al.   NEUROPHARMACOLOGY

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain

(2008) Praveen Anand et al.   BRAIN RESEARCH REVIEWS

Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase

(2008) Victoria L. Haller et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury

(2008) Yun Guan et al.   PAIN

Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons

(2008) Uma Anand et al.   PAIN

Beta-caryophyllene is a dietary cannabinoid

(2008) Jürg Gertsch et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA